Search research articles
Contact Us
Filters
Showing results (41-50 of 88) with videos related to
Page
of 9
Sort By:
Leukemia & Lymphoma
|
June 28, 2001
Thrombopoietin, interleukin-11, and early-acting megakaryocyte growth factors in human myeloid leukemia cells
M T Petrucci, M R Ricciardi, C Gregorj, et al.
Haematologica
|
August 23, 2006
Homozygous p.M172K mutation of the TFR2 gene in an Italian family with type 3 hereditary hemochromatosis and early onset iron overload
S Majore, F Milano, F Binni, et al.
World Journal of Urology
|
November 9, 2019
Is remote live urologic surgery a reality? Evidences from a systematic review of the literature
Domenico Veneziano, A Tafuri, J Gomez Rivas, et al.
Current Pharmaceutical Design
|
August 17, 2005
Beyond single pathway inhibition: MEK inhibitors as a platform for the development of pharmacological combinations with synergistic anti-leukemic effects
M Milella, C M Precupanu, C Gregorj, et al.
Haematologica
|
January 1, 1996
Peripheral blood stem cells in acute myeloid leukemia: biology and clinical applications
M Aglietta, A De Vincentiis, L Lanata, et al.
La Clinica Terapeutica
|
July 5, 2006
[Hairy cell leukemia: prognosis and treatment]
M Quaresima, S Iacobelli, S Tempera, et al.
Blood
|
February 15, 1991
Recombinant human granulocyte-macrophage colony-stimulating factor in combination with standard induction chemotherapy in de novo acute myeloid leukemia
P Bettelheim, P Valent, M Andreeff, et al.
The Journal of Clinical Investigation
|
May 1, 1993
High stimulatory activity of dendritic cells from diabetes-prone BioBreeding/Worcester rats exposed to macrophage-derived factors
A Tafuri, W E Bowers, E S Handler, et al.
Leukemia Research
|
December 1, 1995
Prognostic value of rhodamine-efflux and MDR-1/P-170 expression in childhood acute leukemia
A Tafuri, A Sommaggio, L Burba, et al.
Cytokines and Molecular Therapy
|
December 1, 1995
Multidrug resistance expression and proliferative studies in poor risk acute myeloid leukemia treated with the FLAG (G-CSF plus fludarabine and Ara-C) regimen
A Tafuri, L De Felice, M T Petrucci, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 88) with videos related to
Sort By:
Page
of 9
Leukemia & Lymphoma
|
June 28, 2001
Thrombopoietin, interleukin-11, and early-acting megakaryocyte growth factors in human myeloid leukemia cells
M T Petrucci, M R Ricciardi, C Gregorj, et al.
Haematologica
|
August 23, 2006
Homozygous p.M172K mutation of the TFR2 gene in an Italian family with type 3 hereditary hemochromatosis and early onset iron overload
S Majore, F Milano, F Binni, et al.
World Journal of Urology
|
November 9, 2019
Is remote live urologic surgery a reality? Evidences from a systematic review of the literature
Domenico Veneziano, A Tafuri, J Gomez Rivas, et al.
Current Pharmaceutical Design
|
August 17, 2005
Beyond single pathway inhibition: MEK inhibitors as a platform for the development of pharmacological combinations with synergistic anti-leukemic effects
M Milella, C M Precupanu, C Gregorj, et al.
Haematologica
|
January 1, 1996
Peripheral blood stem cells in acute myeloid leukemia: biology and clinical applications
M Aglietta, A De Vincentiis, L Lanata, et al.
La Clinica Terapeutica
|
July 5, 2006
[Hairy cell leukemia: prognosis and treatment]
M Quaresima, S Iacobelli, S Tempera, et al.
Blood
|
February 15, 1991
Recombinant human granulocyte-macrophage colony-stimulating factor in combination with standard induction chemotherapy in de novo acute myeloid leukemia
P Bettelheim, P Valent, M Andreeff, et al.
The Journal of Clinical Investigation
|
May 1, 1993
High stimulatory activity of dendritic cells from diabetes-prone BioBreeding/Worcester rats exposed to macrophage-derived factors
A Tafuri, W E Bowers, E S Handler, et al.
Leukemia Research
|
December 1, 1995
Prognostic value of rhodamine-efflux and MDR-1/P-170 expression in childhood acute leukemia
A Tafuri, A Sommaggio, L Burba, et al.
Cytokines and Molecular Therapy
|
December 1, 1995
Multidrug resistance expression and proliferative studies in poor risk acute myeloid leukemia treated with the FLAG (G-CSF plus fludarabine and Ara-C) regimen
A Tafuri, L De Felice, M T Petrucci, et al.
Page
of 9